Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 21:10:830280.
doi: 10.3389/fped.2022.830280. eCollection 2022.

Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis

Affiliations
Case Reports

Case Report: Superior Mesenteric Artery Syndrome in an Adolescent With Cannabinoid Hyperemesis

Jonathan A Berken et al. Front Pediatr. .

Abstract

Background: Superior mesenteric artery syndrome (SMAS) occurs when the third portion of the duodenum is compressed between the superior mesenteric artery (SMA) and the aorta, causing duodenal obstruction. This condition most commonly arises from marked weight loss that reduces the size of the fat pad between these vessels, causing greater acuity of angulation. We present an unusual case of SMAS occurring in an adolescent due to precipitous weight loss resulting from cannabinoid hyperemesis syndrome (CHS).

Case presentation: A 17-year-old adolescent presented emergently with voluminous bilious emesis. She endorsed a history of recent weight loss and a longstanding history of chronic heavy cannabis use associated with recurrent nausea and vomiting. Her chronic symptoms satisfied the Rome IV criteria for cannabinoid hyperemesis syndrome, but her acute vomiting symptoms were more extreme. Evaluation was significant for mild abdominal tenderness and fullness of the epigastrium. Contrast abdominal CT demonstrated moderate gastric and proximal duodenal distention with tapering of the lumen between the SMA and the aorta, consistent with SMAS.

Conclusions: To our knowledge, this is the first reported case of SMAS occurring as the result of CHS. Clinicians should be aware of this possible juxtaposition, when a patient with a history of chronic excessive cannabis use, stereotypical vomiting resembling cyclic vomiting syndrome, and considerable rapid weight loss presents with a sudden exacerbation of symptoms, even when a normal BMI is maintained.

Keywords: Rome IV criteria; THC; cannabinoid hyperemesis syndrome; case report; superior mesenteric artery syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Timeline of the patient's clinical history.
Figure 2
Figure 2
The patient's axial CT scan with oral contrast demonstrates the classic findings of superior mesenteric artery syndrome. The arrow points to the narrowed third segment of the duodenum, compressed between the superior mesenteric artery anteriorly and the abdominal aorta posteriorly. The duodenum proximal to the compressed segment is dilated and filled with contrast (circle).
Figure 3
Figure 3
A sagittal CT view of the abdomen with oral contrast reveals dilation of the third portion of the duodenum [(A), circle]. No enteral contrast is seen as the duodenum is compressed between the superior mesenteric artery and the abdominal aorta [(B), arrow].

Similar articles

Cited by

References

    1. Mandarry MT, Zhao L, Zhang C, Wei ZQ. A comprehensive review of superior mesenteric artery syndrome. Eur Surg. (2010) 42:229–36. 10.1007/s10353-010-0561-y - DOI
    1. Welch T, Büchler MW, Kienle P. Recalling superior mesenteric artery syndrome. Dig Surg. (2007) 24:149–56. 10.1159/000102097 - DOI - PubMed
    1. Bilgili Y, Aktaş A. Superior mesenteric artery syndrome: CT and ultrasonography findings. Diag Interv Radiol. (2005) 11:90–5. - PubMed
    1. Venkatesan T, Levinthal DJ Li BU, Tarbell SE, Adams KA, Issenman RM, et al. . Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastro Motil. (2019) 31:e13606. 10.1111/nmo.13606 - DOI - PMC - PubMed
    1. Sorensen CJ, DeSanto K, Borgelt L, Phillps KT, Monte AA. Cannabinoid hyperemesis syndrome: Diagnosis, pathophysiology, and treatment – a systematic review. J Med Toxicol. (2017) 13:71–87. 10.1007/s13181-016-0595-z - DOI - PMC - PubMed

Publication types

LinkOut - more resources